Skip to main content
HR 2639 118th Congress House Health

Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2023

Introduced: April 17, 2023 Introduced by: Sessions, Pete Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Apr 17, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 17, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2023

This bill requires, as a condition for Medicare payment, specified electrodiagnostic services to be furnished by qualified facilities that comply with accreditation, training, and other quality control requirements, as established under the bill.

Specifically, the bill requires nerve conduction studies and needle electromyography tests to be furnished by facilities that are accredited by an organization that is approved by the Centers for Medicare & Medicaid Services (CMS). The accrediting organization must certify that the facility meets certain standards, including having a quality control program and requiring those who administer needle electromyography tests to have at least three months of specialized training.

The bill also establishes an advisory committee to support the CMS in developing appropriate facility standards.

What's happening now December 17, 2024

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 2
All 2 Republican 2
R
Weber, Randy K. Sr.
Texas · May 21, 2024
 R
Smucker, Lloyd
Pennsylvania · Oct 26, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2639: Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-2639/
MLA
"H.R. 2639: Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-2639/.
Bluebook (legal)
H.R. 2639, 118th Cong. (2026), https://openamerica.io/bill/118-HR-2639/.
Markdown link
[H.R. 2639: Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2023](https://openamerica.io/bill/118-HR-2639/)
Report a problem